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ABSTRACT

SHENEE’ K. LAURENCE
ASSOCIATION BETWEEN PREOPERATIVE PULMONARY REHABILITATION AND
POSTOPERATIVE HOSPITAL OUTCOMES
(Under the direction of SHANTA R. DUBE)
INTRODUCTION: Preoperative pulmonary rehabilitation (PPR) is an emerging therapy for
transplant candidates who are awaiting surgery. Research indicates that PPR training has benefits
for improving exercise tolerance, but little researcher exists on the association between PPR on
post-transplant hospital outcomes.
METHODS: The study was a non-probability cross-sectional analysis performed on data for
post-transplant recipients who received either a single or bilateral lung transplant from February
8, 2007 to July 8, 2014. The study sample consisted of 207 transplant recipients. Analyses of the
associations between independent variables: preoperative pulmonary rehabilitation and sixminute walk distance (6MWD) and covariates were performed by logistic regression analysis to
examine the following outcomes: length of stay, hospital readmissions in the first 90 days posttransplant, and the number of hospital readmissions in the first 90 days.
RESULTS: Transplant recipients who participated in preoperative pulmonary rehabilitation had
1.77 times greater odds of being readmitted in the first 90 days post-transplant compared to
recipients who did not participated in preoperative pulmonary rehabilitation. Transplant
recipients whose 6MWD was greater than 207 meters and who participated in preoperative
pulmonary rehabilitation had 4.99 times greater odds of length of staying 12 days or less posttransplant surgery compared to transplant recipients whose walk distance was less than 207
meters and who did not participate in preoperative pulmonary rehabilitation.
CONCLUSION: Pulmonary rehabilitation is an important part of the lung transplant. The
results of this study indicate the importance of preoperative lung transplant on post-transplant
outcomes for transplant recipients.
INDEX WORDS: preoperative pulmonary rehabilitation, six-minute walk distance, length of
stay, lung transplant
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CHAPTER I.
INTRODUCTION
Based on the most up to date data published in February of this year by the Organ
Procurement and Transplant Network website there are currently 1,644 lung transplant
candidates on the national waiting list. In the state of Georgia, there are 28 lung transplant
candidates on the waiting list. The average wait time on the national wait list for a lung
transplant is a year to two years. In Georgia, the average wait time is six months to less than a
year. This extended time spent on the waiting list for a lung transplant could be detrimental to a
waitlisted candidate for two reason. The transplant’s disease progression could deteriorate to the
point where the candidate becomes too ill for transplant surgery. The other reason is due to their
exercise intolerance and their inability to participate in daily exercise; they become too
deconditioned to have lung transplant surgery. These reasons explain the important role
preoperative pulmonary rehabilitation plays for waitlisted transplant candidates. Pulmonary
rehabilitation maintains endurance, strength, and overall good health, which is why participation
in preoperative pulmonary rehabilitation is an important part of the pre-transplant process. There
is evidence that pulmonary rehabilitation can stabilize, and potentially reverse many systemic
manifestations of the disease processes. Pulmonary rehabilitation helps with advanced lung
disease management and improvements in quality of life (Yusen et al., 2010).
Since the middle of the 20th century, pulmonary rehabilitation and its components have
been used by clinicians. During this time, the use of pulmonary rehabilitation was based on
expert opinion from trial and error. The first randomized clinical trial of pulmonary rehabilitation
occurred in 1991, with a small group of 19 recipients diagnosed with chronic obstructive
pulmonary disease (COPD). The aim of the study was to see if recipients experienced marked
improvement with higher or lower levels of exercise training which using a cycle ergometer.
Results of the study showed higher levels of training correlated to better outcomes. In 1994, the
first study related the effects of pulmonary rehabilitation and dyspnea demonstrated that
pulmonary rehabilitation can decrease ventilatory demand and reduction in post- exercise
dyspnea. In 1996, the first large randomized control trial of 119 recipients diagnosed with
COPD, received treatment at a comprehensive outpatient pulmonary (which included education
and exercise training). The results of the program showed improvements, but a decline in the
improvements after 18 months. Over the next 11 years, pulmonary rehabilitation would reach
1

several milestones. In 2007, the American College of Chest Physicians (ACCP) and the
American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) documented
very strong evidence supporting the effectiveness of upper and lower extremities in exercise
training. They also recorded improvements in dyspnea and quality of life. The ACCP and
AACVPR summarized the current evidence-based guidelines for pulmonary rehabilitation. In
2008, pulmonary rehabilitation became the most effective therapy in increasing exercise capacity
of COPD recipients and was added to the current treatment algorithm for COPD by the Global
Initiative for Obstructive Lung Disease (GOLD). Pulmonary rehabilitation became a covered
benefit for selected aspects of COPD under the Centers for Medicare and Medicaid (CMS) in
January 2010 (Nici & Zuwallack, 2011).
Statement of the Problem
Due to the exercise intolerance caused by to physiology changes of end-stage lung
disease, many recipients are often much more deconditioned than recipients without end-stage
lung diseases prior to lung transplantation surgery. A person’s pre-transplant physical activity
status is contributory to their post-transplant physical function. Limited physical activity prior to
a major surgery such as lung transplantation, increases an individual’s morbidity and mortality
during their hospital stay.
Purpose of the Study
There are numerous studies on the benefits of pulmonary rehabilitation after lung
transplantation, but few studies exist on the benefits pre-transplant. This retrospective study
determines if there is an association between participation in preoperative pulmonary
rehabilitation and hospital outcomes. The next chapter will the review the current literature on
preoperative pulmonary rehabilitation in non-restrictive and restrictive lung diseases and the
benefits of preoperative pulmonary rehabilitation for waitlisted lung transplant candidates.
Research Questions:
The researcher sets out to understand the impact of preoperative pulmonary rehabilitation
on the number of hospital readmissions in the first 90 days post-transplant. Specifically, the
research will determine the relationship of preoperative pulmonary rehabilitation and 6MWD on
hospital outcomes.
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Research Question 1: Do lung transplant recipients who engaged in preoperative pulmonary
rehabilitation differ on post-operative hospital readmissions compared to those who did not
engage in preoperative pulmonary rehabilitation?
H01: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have
an equal odds of being readmitted post 90 days compared to lung transplant recipients who did
not engage in preoperative pulmonary rehabilitation.
H02: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have
an equal odds of having < 2 readmissions when compared to lung transplant recipients who did
not engage in preoperative pulmonary rehabilitation.

Research Question 2: Do lung transplant recipients who engaged in 6MWD differ on hospital
length of stay post-surgery compared to those who did not engage in a 6MWD?
H01: Lung transplant recipients who engaged in 6MWD will have an equal odds of having ≤ 12
day stay compared to lung transplant recipients who did not engage in 6MWD.

Exploratory Research Question 3: Do lung transplant recipients who did not engage in both
preoperative pulmonary rehabilitation and 6MWD differ on hospital admissions from those who
engaged in at least one or both of the preoperative behaviors?
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CHAPTER II
LITERATURE REVIEW
A literature review was conducted to examine the body of literature that was relevant to
the research question: Does preoperative pulmonary rehabilitation among lung transplant
recipients result in reduced hospital readmissions in the first 90 days after lung transplant
surgery? Prior to selecting the research articles, the researcher reviewed the definition of
pulmonary rehabilitation to ensure the literature review captured the broad definitions of
pulmonary rehabilitation and how preoperative pulmonary rehabilitation is beneficial.
A literature search was performed using the following databases: PubMed, PubFacts,
Google, and ERIC. The following search terms were used to conduct literature review: definition
of pulmonary rehabilitation, home-based pulmonary rehabilitation, outpatient pulmonary
rehabilitation, preoperative rehabilitation and transplant candidates, benefits of pulmonary
rehabilitation and the following diseases: COPD, Cystic Fibrosis, Idiopathic Pulmonary
Fibrosis, Pulmonary Hypertension, Bronchiectasis, Pulmonary Fibrosis, and Sarcoidosis,
exercise testing determines survival, and 6 MWD prognostic factor and survival in transplant
recipients. This literature review’s organized in the following thematic format (a) definitions of
pulmonary rehabilitation, (b) pulmonary rehabilitation settings, (c) general benefits of
preoperative pulmonary rehabilitation for COPD and non-COPD diseases; (d) benefits of
preoperative pulmonary prior to lung transplant surgery; and (e) 6MWD as determinants of
survival for transplant candidates.
Definitions of Pulmonary Rehabilitation
In 2006, the American Thoracic Society (ATS) and European Respiratory Society (ERS)
adopted a new definition of pulmonary rehabilitation. They defined pulmonary rehabilitation as:
“Pulmonary rehabilitation is an evidence-based, multidisciplinary and comprehensive
intervention for recipients with chronic lung disorders who are symptomatic and have some
disability. Pulmonary rehabilitation is aimed to decrease symptoms, optimize functional state,
increase participation, and reduce health-care costs through stabilizing or reversing systemic
manifestations of the disease” (Nici et al., 2006). The ATS and ERS’ broader definition of
pulmonary rehabilitation is a strategic patient-centered intervention plan where the goal is the
4

lifelong management of patient’s chronic respiratory symptoms. The patient-centered
intervention plan should be a dynamic multidisciplinary collaboration among the patient, family,
and healthcare workers. The aim of the intervention program is to address both the primary and
secondary deteriorations of the recipients’ disease process.
Pulmonary rehabilitation programs, as described by Troosters, Grosselink, Janssens, and
Decramer (2010), are exercise training intervention programs with a multidisciplinary approach.
A simpler is definition is an exercise program used to reverse the systemic skeletal muscle
dysfunction in respiratory diseases. The aim of the pulmonary rehabilitation program should be
to increase ventilatory efficiency, reduced dyspnea, and increased exercise capacity and to be
performed at a minimum of 3 times per a week for at least eight weeks.
Nici & Zuwallack, (2011) define pulmonary rehabilitation as comprehensive
interventions for recipients with chronic advanced respiratory disease. These are recipients who
are symptomatic and have experience decreased daily life activities. Pulmonary rehabilitation
interventions would reduce symptoms, improve functional status, increase participation and
reduce healthcare costs.
With the advances in the understanding of the science and processes of pulmonary
rehabilitation, in 2013 the ATS and ERS decided to update the definition of pulmonary
rehabilitation. The first definition of pulmonary rehabilitation created seven years prior was an
evidence-based, multidisciplinary approach for treating advanced chronic respiratory diseases
with the focus on stabilizing the disease reversing and systemic manifestations. The ATS and
ERS gained a more comprehensive understanding of the parts of pulmonary rehabilitation
combined with years of clinical experience and expert opinion. With this newfound
understanding, the ATS and ERS revised the definition of pulmonary rehabilitation
interdisciplinary intervention for recipients with any respiratory disease that included focus on
behavior modifications. The ATS and ERS’ new adopted definition stated: “Pulmonary
rehabilitation is a comprehensive intervention based on a thorough patient assessment followed
by patient-tailored therapies, which include, but are not limited to, exercise training, education,
and behavior change, designed to improve the physical and psychological condition of people
with chronic respiratory disease and to promote the long-term adherence to health-enhancing
behaviors.” (Martijn et al., 2013).
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The new ATS and ETS’ definition of pulmonary rehabilitation is a more individualized
patient-centered intervention. The main components of the pulmonary program: exercise
training, self-management education, and behavioral modification remain the same as the
pulmonary rehabilitation program defined in 2006. The format of the pulmonary rehabilitation
programs may vary. Similarly, the indication for pulmonary rehabilitation no longer is restrained
to recipients suffering from COPD but to recipients who illustrate symptoms of shortness of
breath at a regular pace on level ground while on optimum therapy. Pulmonary rehabilitation
should be individualized including age specific, cultural sensitive, and both patient and family
involvement (Al Moamary, Aloniny, & Al-Hajjaj, 2014). The team involved should include
interdisciplinary team members (i.e. physicians, respiratory therapists, nurse, social workers, or
occupational therapists). The focus of the interventions should be unique to the needs of the
recipients, based on initial, current and ongoing assessments. The interventions should be in
direct correlation with the patient’s disease severity, complexity, and comorbidities (Martijn,
2013).
The use of the term ‘intervention’ for pulmonary rehabilitation has the implied meaning
that pulmonary rehabilitation is to be prescribed as a treatment plan. Troosters, Gosselink,
Janssens & Decramer (2010), state there are reported extensive benefits of pulmonary
rehabilitation in stable lung disease recipients. However in recipients with milder disease there is
limited efficacy of pulmonary rehabilitation due to limited substantial evidence. This is evident
in a trial conducted in recipients with a forced expiratory volume less than 60% in one second
only showed modest improvements after pulmonary rehabilitation.
Contrarily, Martijn et al. shows with more clinically expert based data pulmonary
rehabilitation can be integrated throughout the clinical course of a patient’s disease; therefore it
can be initiated at any stage of the disease. Pulmonary rehabilitation can be recommended during
periods of clinical stability or directly after an exacerbation. The goal of pulmonary rehabilitation
is to minimize symptom burden and maximize exercise performance. While promoting
autonomy pulmonary rehabilitation, increasing participation in activities of daily living, quality
of life, and enhancing long-term health changing behavior (2014).
Complementary to this, Troosters, Hornikx, Demeyer, Camillo, Janssens (2014), agree
there are recipients who should be prescribed pulmonary rehabilitation without hesitation.
Recipients who have recently been admitted to the hospital with acute COPD exacerbations and
6

recipients with severe dyspnea in whom all pharmacologic options have been exhausted. The
potential beneficial gains of pulmonary rehabilitation for these two group of recipients is
essential for their lung function.
Pulmonary Rehabilitation: Hospital-based and Home-based Pulmonary Rehabilitation
Traditionally, pulmonary rehabilitation programs were performed in hospital-based
facilities. In the early 1990s, home-based pulmonary rehabilitation programs became popular
options for recipients. The current trend is hospital-based pulmonary rehabilitation programs.
Inpatient pulmonary programs are thought to be the optimal pulmonary rehabilitations setting for
lung transplant recipients to receive pulmonary rehabilitation in terms of setting, supervision,
complexity, and duration. As the burden of end-stage lung disease continues increases and rising
healthcare costs perhaps a way to increase the number of transplant recipients in pulmonary
rehabilitations is to approve home-based programs. There naturally will be challenges in the
funding and management of home based programs, but the pros of home-based pulmonary
programs far outweigh the cons.
A group of researchers have completed studies analyzing the efficacy of home-based
pulmonary rehabilitation programs compared to hospital-based programs (Mathis et al., 2008;
Mendes de Oliveira et al., 2008).
Malthis et al. (2008) completed a study of 252 recipients who after a 4-week education
program took part in home-based rehabilitation or hospital-based rehabilitation for eight weeks.
The transplant recipients were followed for 40-weeks to complete a one year study. The results
of the study showed improved cycling endurance time at three months, both groups associated
with statistically and clinically significant improvement in health status. Overall at three months
and one year both rehabilitation strategies, home-based and hospital-based, had similar efficacy
in 6MWD, endurance time, and improvements in dyspnea. The clinical trial provides evidence
that using self-monitored home-based pulmonary rehabilitation may be a viable option for
recipients.
The results of the randomized controlled prospective study by Merdes de Oliveira et al.
revealed the clinical benefits (6MWD) achieved in the clinical setting were not significantly
greater than those achieved in the self-monitored home modality. The results of this study also
revealed another positive aspect the retention rate of participation. The dropout rate was notably
less in the at home group than in the hospital-based group. The researchers feel the positive
7

results of this study demonstrate home-based pulmonary rehabilitation is logistically easier and
will have greater patient adherence due to non-necessity of transportation to specialized clinics
(2010).
The benefits of home-based pulmonary rehabilitation were shown to extend to recipients
with restrictive lung diseases in a study conducted by Kapaya, Takahaskhi, Sugawara, Kasai,
Kiyokawa, and Shioya (2009). The study was a multidisciplinary home-based program. The
home-based program included: exercise training with upper and lower limb exercises, respiratory
muscles stretching calisthenics, level walking for at least 15 minutes inspiratory and expiratory
muscles forces and a 45 minute education class. The results of the study showed that PR for
restrictive lung diseases has the same effects as recipients with COPD if the severity of the
disease was similar. The restrictive lung disease group had increases in six-minute walk distance,
exercise intolerance, and quality of life.
Conversely, Elliott et al., (2011) tested the effect of home-based program on the recovery
of lung transplant recipients. The study was an individualized eight week home-based physical
rehabilitation program. The program was conducted through a multi-center randomized
controlled trial to assess the physical function of pulmonary rehabilitation on recipients who
survived a critical illness. The results of the study revealed the home-based rehabilitation both
groups did have improvements in physical endurance. The researchers contribute the lack of a
significant improvement due to lack of compliance since sessions were unsupervised, and
training intensity was not adequate.
For most of the comparison research on hospital-based versus home-based pulmonary
rehabilitation; there is evidence of results showing the efficacy of home-based programs if
recipients are well selected and supervision is provided.
Respiratory Illnesses Potentially Requiring Lung Transplantation
Chronic obstructive pulmonary disease (COPD) is a type of lung disease where
airflow is chronically obstructed. This obstructed airflow interferes and prohibits normal
breathing; COPD is not fully reversible and is the third leading cause of death in United States.
The prevalence of COPD among adults in the United States varies considerably by state and
region. The prevalence of COPD is less than 4% in Washington and Minnesota compared to
greater than 9% in Alabama and Kentucky. The area in the United States with the highest COPD
prevalence cluster is along the Ohio and lower Mississippi Rivers. There has been declined in the
8

number of deaths related to COPD in men (10.6 per 100,000 between 1999 and 2010).
Unfortunately, there has been no significant change in death rate had occurred in women. The
prevalence rates for women were 35.3 per 100,000 in 1999 and 36.4 per 100,000 in 2010
(“COPD among Georgia Adults”, n.d.).
Individuals in the state of Georgia with COPD are more likely to be Caucasian, age 55
years or older, female, unable to work and have less than a high school diploma. A current
household income of less than $25,000 are divorced, separated or widowed and have a history of
smoking or asthma (http://www.cdc.gov/copd/data.htm). The demographics of Georgians with
COPD are summarized in the table below.
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Table 1.1 Demographics of Georgia Adults with
COPD (data obtained from 2011 BRFSS)
Characteristics
Age Group (Years)
18-44
45-54
55-64
65-74
>75
Race/Ethnicity
White
Black
Hispanic
Other
Gender
Male
Female
Employment Status
Employed
Unemployed
Homemaker/Student
Retired
Unable to work
Education
Less than high school diploma or GED
High school diploma or GED
At least some College
Income
<$25,000
$25,000-$49,999
$50,000-$74,999
>$75,000
Marital Status
Married
Divorced/Widowed/Separated
Never Married
Member of Unmarried Couple
Smoking Status
Current Smoker
Former Smoker
Never Smoked
Ever had Asthma
Yes
No

Percentage %
3.8
7.4
11.5
13.7
12.4
8.3
5.4
0
7.8
5.6
8.2
2.7
8.5
4
11.8
29
14.7
7.2
4.3
12.3
5.7
3.6
2.1
6
13.8
3.6
0
14.2
9.2
3.4
25.3
4

Interstitial lung diseases (ILD) this is a broad term that describes a collection of over 200
chronic lung diseases. These respiratory diseases are grouped together based on how the affect
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the respiratory system-lack
lack of these diseases affect the tissue space around alveoli (air sacs), the
interstitium, and may also affect other compartments of the lungs, the alveoli, the trachea,
bronchi, blood vessels and pleura. There are four main manifestations of ILD: a) shortness of
breath and cough, b) specific chest radiographic abnormalities, c) decrease in lung volume on
pulmonary function tests, d) characteristics microscopic patterns of inflammation and fibrosis.
ILD was considered a rare disease, but unfortunately the prevalence of ILD has increased. In the
United States 80.9 per 100, 000 men and 67.2 per 100,000 women suffer from ILD, with 31.5
new cases for men and 26.1 new cases per 100,000 for women diagnosed every year. The most
commonly diagnosed ILD diseases included pulmonary fibrosis, occupational and environmental
associated disease, and sarcoidosis. IPF affects adults, most often occurs between ages of 40 and
70, butt may occur earlier in these with a history of IPF. IPF is more common and deadly in
Caucasian than in African Americans (“Interstitial lung disease”, 2012).
Cystic fibrosis is the second most common life shortening hereditary disease in the
United States after sickle cell anemia. Symptoms of cystic fibrosis are salty tasting skin,
wheezing or shortness of breath, persistent cough and excessive mucus, frequent lung infections
(pneumonia and bronchitis), frequent sinus infections, nasa
nasall polyps, poor weight gain and
growth, fouls-smelling
smelling greasy stools, and broadening of fingertips and toes. In the United States
there are approximately 30,000 Americans diagnosed with CF and 1,000 new cases are
diagnosed yearly. Cystic fibrosis equally af
affects
fects males and females, while it does occur in nearly
every race, Caucasians off Northern European descent are more often diagnosed with cystic
fibrosis, with every 1 in 2500 Caucasian births being affected. The median age survival for a
person with cystic fibrosis without a lung transplant is 37.4 years; the age adjusted death rate is
higher for Caucasians (0.22 per 100,000) than other racial and ethnic groups (“Cystic Fibrosis,
n.d).

Table 1 Cystic Fibrosis Age Adjusted Death Rates
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Bronchiectasis (non-cystic fibrosis) is a chronic condition characterized by irreversible
widening of the medium sized airways with inflammation, chronic bacterial infection and
destruction of the bronchial walls. The characteristic features are abnormally dilated thick-walled
bronchi that are inflamed and chronically infected by bacteria. The symptoms of non-CF
bronchiectasis vary from person to person; some recipients have no symptoms at all, some
recipients have symptoms only during exacerbations, and other recipients have experience
symptoms daily. The clinical manifestations of non-CF bronchiectasis are persistent cough with
daily micropurulent sputum production (lasting months to years), recurrent pulmonary infections
resulting in airway damage which may produce streaked sputum and hemoptysis, dyspnea,
wheezing, pleuritic chest pain, and adventitious breath sounds (crackles, wheezing, or rhonchi)
[Neves, Guerra, Ponce, Miranda, and Vouga, 2011].
In analysis of US health plan claims for over 46 healthcare plans in 2009, Dwibedi, Joish,
Spilsbury-Cantalupo, Operschall and Luong (2012), found the prevalence of non-CF
bronchiectasis increased with increasing age; prevalence was lowest among individuals younger
than 18 years of age (4.48 per 100,00) and highest among individuals 75 years of age and older
(378.74 per 100,000). In terms of gender differences non-CF bronchiectasis was more prevalent
among women. Dwibedhi et al. also noted regional variations across nine census regions with
Middle Atlantic Regions having the highest prevalence at 57.29 per 100,000 and west North
12

Central regions having the lowest prevalence of non-CF bronchiectasis at 28.60 per 100,000
(2012).
In another study of US Medicare data, the 8 year period of prevalence of non-CF
prevalence increased by 8.7% per year of life. The report also suggested in terms of ethnicity
there is a higher prevalence among Asians compared to African Americans and EuropeanAmericans (“Bronchiectasis”, 2012).
Pulmonary hypertension is a respiratory illness which there is high blood pressure in the
lung arteries; the arteries narrow and decreases blood flow. Over time the arteries stiffen and
become blocked – this narrowing of the pulmonary arteries over times causes stress on the heart
and leads to the enlarge heart and heat failure. The symptoms of pulmonary hypertension during
the initial stage of the disease are common to many other medical conditions: difficulty
breathing, fatigue, shortness of breath. As the disease progresses the symptoms become more
severe: dizziness, chest pain, ankle swelling, and palpitations.
Due to lack of specific ICD-9 codes for the conditions of pulmonary hypertension and
risk of misdiagnosis; the exact prevalence of PH is largely unknown. Kirson et al analyzed
private insurance claims and Medicare database claims from 1999 to 2007. The results of the
data analysis revealed the prevalence rates of PH increases with age and are higher among
women. The data analysis also showed the estimated US prevalence of PH is higher than existing
estimates (Kirson, Birnbaum,Ivanova, Waldmen, Joish, and Williamson, 2011).
As the above diseases progress and become more debilitating, lung transplantation is the
therapeutic measure for recipients with end-stage lung diseases who have exhausted all other
available treatments without improvements. In order to become a transplant recipients there are
certain criteria candidates have to meet prior to transplantation. While the requirements vary
from transplant center these are the generally agreed upon criteria:
•

End-stage lung disease

•

Has exhausted other available therapies without success

•

No other compounding comorbidities involving heart, kidney, liver

•

No HIV, untreated Hepatitis, cancers

•

Not currently using/abusing alcohol, smoking, drug abuse

•

Acceptable BMI (usually above the range of malnourished and below the range of
obese)
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•

Age

•

Acceptable psychological profile

•

Adequate social support

•

Financial able to pay for expenses post-transplant

•

Able to comply with post-transplant regimen.

•

Acceptable results from extensive medical tests which evaluate their overall
health status and suitability for transplant surgery

Once a person is accepted as by a transplant center, they are added to recipient waiting
list and assigned a lung allocation score (LAS). The LAS takes into account various measures of
the patient’s health. The LAS system allocates donated lungs according to the immediacy of
need rather than how long a patient has been on the transplant list.
The following table is information from UNOS database illustrating the number of lung
transplants completed from January 1, 1998 to November 30, 2014.

Table 1.2 Number of Lung Transplants performed from January 1, 1999 to November 30,
2014
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Caucasian
Male
Female
Caucasian Total
African American
Male
Female
African American Total

COPD

Cystic
Fibrosis

Non-CF Bronchiectasis

Pulmonary
Hypertension

ILD

Total

3941
4180

1834
1612

173
202

232
489

4516
1656

10696
8139
18835

219
240

17
21

23
9

11
56

258
266

528
592
1120

Hispanic
Male
Female
Hispanic Total
Unknown
Male
Female
Unknown Total
Asian
Male
Female
Asian Total
American
Indian/Alaskan Native
Male
Female
American
Indian/Alaskan Native
Total
Pacific Islander
Male
Female
Pacific Islander Total

63
43

47
45

19
35

19
40

391
217

539
380
919

0
1

1
0

0
1

0
0

1
1

2
3
5

14
8

1
0

9
9

3
15

98
42

125
74
199

5
10

3
2

2
1

7
4

14
14

31
31

62
0
1

0
0

1
1

2
2

6
2

9
6
15

Multi-Racial
Male
Female
Multi-Racial Total
Total

4
12

0
2

2
1

1
1

7
9

14
25
39

8741 (31.6
%)

3585
(13.0%)

488
(1.8%)

875
(3.2%)

7498
(27.1%)

21187
(76.7%)

on Adults Living in the United States

Physiology of Exercise Intolerance in Obstructive and Restrictive Respiratory Diseases
There is a direct association between obstructive respiratory diseases, such as COPD and
ventilatory constraints, abnormal pulmonary gas exchange, peripheral muscle dysfunction,
cardiac dysfunction, and limitations due to lower limb and respiratory muscle dysfunction. Each
of these processes alone or a combination of can lead to exercise intolerance.
Ventilatory limitations. Spruitt et al. describe the ventilatory limitations
(constraints) requirements experienced by recipients diagnosed with COPD are due to increase
work of breathing, increased dead space ventilation, impaired gas exchange and increased
ventilatory demand as a consequence of deconditioning and peripheral muscle dysfunction. The
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increase in demand causes a limit in the maximum ventilation during exercise resulting in two
respiratory symptoms of COPD: expiratory airflow obstruction and hyperinflation. Expiratory
airflow obstruction and hyperinflation lead to further increased work of breathing, increased load
and mechanical constraints on the respiratory muscles-this leads to an increasing intensified
sense of dyspnea (2013).
Gas exchange limitation. Pulmonary ventilation increases as a direct result of hypoxia.
Hypoxia causes an increase in pulmonary ventilation by changing peripheral chemoreceptor
outputs and indirectly stimulating lactic acid production. This process causes a set of change
reactions: lactic academia occurs as a result of anaerobic metabolism by the muscles during
higher intensity exercise; leads to failure of the muscle tasks and thus increases pulmonary
ventilation. Lactic acid buffering results in an increase in carbon dioxide production and acidosis
stimulating the carotid bodies (Martijn et al., 2013).
Cardiac limitations. Chronic respiratory disease also affect the cardiovascular system in
numerous ways: the main way is an increase in the right ventricular afterload. The consequences
of overloaded right ventricular may lead to right ventricular hypertrophy and failure which can
cause compromise left ventricular filling by producing septal shifts, which further decreases the
hearts ability to meet exercise demands leading to tachyarrhythmias or right atrial pressure
(Martijn, 2012).
Limitations due to lower limb and respiratory muscle dysfunction. The peripheral
muscle dysfunction experienced in recipients with COPD is caused by single or multifactorial
causes: inactivity induced deconditioning, systemic inflammation, oxidative stress, smoking,
blood gases disturbances, nutritional imbalances, abnormally low hormone levels, aging, or
prolonged corticosteroid use. Other factors leading to skeletal muscle dysfunction is the
increased ventilatory requirements recipients with COPD experience with any given exercise
work rate, which causes an increasing burden on the respiratory muscles (Martijn et al., 2012).
In order to adapt to chronic overload the diaphragm of individuals with COPD have
greater resistance to fatigue; the inspiratory muscles are capable of generating more pressure
than non COPD individuals. While this resistance to fatigue may be seen as an advantage it
actual causes recipients with COPD to experience static and dynamic hyperinflation, which
places their muscles at a mechanical disadvantage. Even with the adaptation in their diaphragm
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individuals with COPD still experience both inspiratory muscle strength and inspiratory muscle
endurance weakness, which causes reduced exercise performance (Martijn, 2013).
Research has shown the physiology effects of exercise intolerance of restrictive lung
disease are similar to the symptoms of obstructive respiratory disorders. These restrictive lung
conditions are, but not limited to, interstitial lung disease, non-cystic fibrosis bronchiectasis, and
pulmonary arterial hypertension.
Exercise intolerance is a key feature in restrictive lung disorders and characteristic
symptoms are dyspnea on exertion or hypoxemia. Exercise intolerance in restrictive respiratory
diseases are caused by many of the same mechanisms as obstructive respiratory diseases:
impaired gas exchange, circulatory limitations, altered respiratory mechanisms, abnormalities in
muscle oxygen extraction and utilization, abnormal breathing patterns, and dynamic
hypoinflation during exertion (Markovitz and Cooper, 2010).
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Benefits of Pulmonary Rehabilitation on Exercise Intolerance and Prior To Lung Transplant Surgery
Literature Review of the Benefits of PR for Obstructive Respiratory Diseases
Author/title
Pulmonary
rehabilitation improves
cardiovascular response
to exercise in COPD.

Study Aim

Sample
27 recipients diagnosed
with COPD who
participated in 9 week
pulmonary rehabilitation
program

Results
transplant recipients experienced
enhanced ventilatory capacity while
exercising which lead to an enhancement
in their breathing patterns. This
enhancement in their breathing pattern
was associated with reduced with dynamic
hyperinflation and also improved exercise
intolerance

Lan et al.

The effects of PR
in patients with
normal exercise
capacity on healthrelated quality of
life and exercise
capacity.

revealed two positive effects of
pulmonary rehabilitation on ventilatory
limitations: improved the exercise
capacity and level of exertional dyspnea.
The scores of dyspnea at the end of the
exercise pre-pulmonary rehabilitation was
5.7. The scores of dyspnea decreased by
0.9 points post-pulmonary rehabilitation.
The scores of the level of exertional
dyspnea post pulmonary rehabilitation
were nearly that of healthy subjects.

Exercise dyspnea in
patients with COPD

Review of exercise
dyspnea in COPD

Twenty-six subjects with
COPD and normal exercise
capacity were studied. All
subjects participated in 12week, 2 sessions per week,
hospital-based, out-patient
PR. Baseline and post-PR
status were evaluated by
spirometry, the St George's
Respiratory Questionnaire,
cardiopulmonary exercise
test, respiratory muscle
strength, and dyspnea
scores.
None

Ramponi et al.

Benefits of pulmonary
rehabilitation in
patients with COPD
and normal exercise
capacity.

Stendardi, Binazzi,
and Scano

Despite the unaltered ventilatory
equivalents for carbon dioxide, pulmonary
rehabilitation produces less Borg per unit
of change in ventilation; which results in
improved mechanical efficiency. To
summarize the effects of pulmonary
rehabilitation has on gas exchange
exercise training reduces dyspnea by
reducing the inspiratory effort, endexpiratory-lung-volume and respiratory
rate. The end effect is a reduction in the
respiratory effect to concurrent volume

1

Implications for practice, research, theory

Literature Review of the Benefits of PR for Obstructive Respiratory Diseases
Author/title
Severe exerciseinduced hypoxemia.

Study Aim
Review of severe
exercise-induced
hypoxemia

Sample
None

Evaluate the effects
pulmonary
rehabilitation has on
the impaired cardiac
autonomic
modulation in
recipients with
COPD which causes
depressed heart rate
variability.

Sixty-four patients
with COPD
participated in a 12week, 2 sessions-perweek, hospital-based
PR program.
Baseline and post-PR
status were evaluated
by spirometry,
HRV, healthrelated quality of life
(HRQL, St. George's
Respiratory
Questionnaire,
SGRQ),
cardiopulmonary
exercise test,
respiratory muscle
strength, and dyspnea
Borg's scale.

To evaluate the
effects of wholebody resistance
training on exercise
capacity, healthrelated quality of
life (HRQOL), and
muscle strength in
patients hospitalized
for exacerbation of
chronic obstructive
pulmonary disease

Patients (N=46) were
randomized to either
a control group (CG)
or training group
(TG), and 29 patients
completed the study

Garvey, Tiep, Barnett,
Carter, Hart and
Casaburi

Pulmonary rehabilitation
improves heart rate varia
bility at peak exercise,ex
ercise capacity
and healthrelated quality of life in c
hronic obstructivepulmo
nary disease.
Cheng, Wu, Yang,
Huang C., Huang H.,
Chu W., and Lan C

Impact of resistance
training in chronic
obstructive pulmonary
disease patients during
periods of acute
exacerbation
Borges, RC and
Carvalho, CR

Results
Recommended oxygen saturation should be the
center of monitoring of a pulmonary
rehabilitation program to improve hypoxia
experienced by recipients suffering from COPD.
Contrary to other studies which have
recommended high intensity workouts, Garvey et
al are recommending low intensity exercise in
initial states of exercise, until clinical baselines
are defined such as dyspnea levels, oxygen
saturation, and heart rate.
Despite the unaltered ventilatory equivalents for
carbon dioxide, pulmonary rehabilitation
produces less Borg per unit of change in
ventilation; which results in improved
mechanical efficiency. To summarize the effects
of pulmonary rehabilitation has on gas exchange
exercise training reduces dyspnea by reducing
the inspiratory effort, end-expiratory-lungvolume and respiratory rate. The end effect is a
reduction in the respiratory effect to concurrent
volume

Implications for practice, research, theory

Increases muscle strength and improves exercise
capacity in recipients with COPD. The
researchers believe the peak improvement in
muscle strength was directly related to an
improvement in neurologic adaptation.

The researchers concluded that pulmonary rehabilitation can be a
useful intervention to reduce or prevent decreases in muscle
strength during hospitalizations
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The results of the study showed a significant improvement in
autonomic modulation at peak exercise after pulmonary
rehabilitation. The improvements in autonomic modulation not only
occurred at peak exercise but also during periods of rest. The
authors contribute the reason for the marked improvement in
autonomic modulation is related to exercise training re-establishes
exercise tolerance, decreases ischemic metabolites during exercise
and further reduces sympathetic activity. In conclusion pulmonary
rehabilitation decreased parasympathetic activity and increased
sympathetic activity, improved the balance between
parasympathetic and sympathetic activities, and improved heart rate
variability.

Predictors of benefit
following pulmonary re
habilitation for interstit
iallung disease
Holland et al

evaluate the impact
of pulmonary
rehabilitation on the
severity of ILD

Literature Review of the Benefits of PR for Obstructive Respiratory Diseases
The results of this study prove the benefits of pulmonary
prospective study of
The results of the study showed improvement in
rehabilitation for IPF are greater when delivered early in the course
44 subjects with ILD
functional exercise capacity for people with IPF.
of the disease, but regardless of disease severity individuals with
The differences in the improvement in the
ILD are still likely to achieve sustained improvements in dyspnea
functional exercise capacity of individuals with
IPF compared with individuals with COPD is the and quality of life
improvements were related to markers of disease
severity and prognosis. The highest peak of
improvements were seen when the disease was at
its mildest. ILD is one of the least commonly
referred disease processes for pulmonary
rehabilitation because many physicians feel the
benefits are unproven.
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Literature Review of the Benefits of PR for Restrictive Lung Diseases
Author/title
Respiratory muscle
function in patients
with cystic fibrosis.
Dassios, Katelri
Doudounakis and
Dimitriou

Exercise programme
in recipients with
cystic fibrosis: A
randomized controlled
trial
Rovedder et al.

Safety and efficacy of
exercise training in
various forms of
Pulmonary
hypertension.
Grunig et al., 2012

Study Aim
the beneficial role of
exercise in maintain
their health and to see
the effects of regular
exercise on the
respiratory muscle
function indices

Sample
44 cystic fibrosis
recipients

Results
The results of the study indicate that exercise
training is beneficial for individuals with cystic
fibrosis. Exercise training leads to strengthening of
the respiratory muscles which will aid in
maintaining ventilatory balance.

Implications for practice, research, theory
The results of the study indicate that exercise training is
beneficial for individuals with cystic fibrosis. Exercise
training leads to strengthening of the respiratory muscles
which will aid in maintaining ventilatory balance

randomized
controlled study of
46 transplant
recipients with a pretransplant diagnosis
of COPD
demonstrated
participation in
resistance training as
part of pulmonary
rehabilitation
program

clinical trial of adults
with CF, who
participated in homebased pulmonary
rehabilitation program
with aerobic training
and muscle strength
training

The results of this study are an outlier as many of the present
CF studies have shown several benefits of pulmonary
rehabilitation including an increase in muscle mass, muscle
strength, body weight, and a decrease in residual volume
which attributes to great flexibility and thoracic mobility

The efficacy and
safety of respiratory
and exercise training
in recipients
diagnosed with
pulmonary
hypertension

183 patients with PH
(pulmonary arterialhype
rtension (PAH), chronic
thromboembolic PH
and PH due to
respiratory or left heart
diseases
received exercise trainin
g in hospital for 3
weeks and continued at
home.

did not show any positive effects in muscle strength
of the lower limbs or aerobic condition. Rovedder
et al. (2014) explain the lack of gain in muscle
strength as a result of the difference in the size of
the muscle groups exercised. Another reason for no
effect in muscle strength was the study time may
have been too short for effects of training to be
seen. To explain no improvement in the aerobic
condition of recipients who participated in
pulmonary rehabilitation, Rovedder et al (2014)
contributed this to the recipients’ combination of
previous illness and lack of physical activity which
would contribute to low tolerance to exercise and
limited gain in fitness
The results of the study showed that exercise
training can improve the quality of life, peak
oxygen consumption, exercise capacity, oxygen
pulse even in recipients who are classified in WHO
functional class IV (individuals who are unable to
carry out any physical activity without symptoms;
these recipients typically display symptoms of
fatigue even at rest and discomfort is increased
with activity). However, PH is different than other
non-COPD diseases in response to pulmonary
rehabilitation. The effects of exercise training is
independent on the etiology of PH
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Literature Review of the Benefits of Pulmonary Rehabilitation Prior to Lung Transplant
Author/title

Study Aim

Sample

Results

Pulmonary rehabilitation in
lung transplant candidates

randomized controlled
study of 46 transplant
recipients with a pretransplant diagnosis of
COPD demonstrated
participation in
resistance training as
part of pulmonary
rehabilitation program

a retrospective cohort
study of recipients 18
years of age and older
who have received a
single, double, or
heart-lung transplant
between January 2004
and June 2009 at
Toronto General. The
recipients had to have
pre-transplant exercise
data available. The
recipients participated
in pulmonary
rehabilitation during
the entire waiting
period three times a
week for 1.5 to 2 hour
sessions.
111 recipients,
diagnosed with
bronchiectasis who
participated in a
retrospectively study,
demonstrated
individuals with
bronchiectasis achieve
improvements in
exercise capacity and
quality of life after
participating in a 6
week to 8 week
outpatient pulmonary
program
Thirty patients with
clinically
significant bronchiecta
sis and limited
exercise tolerance
were randomized into
either the control or
intervention group.

The results of the study did not show an improvement in the
recipients 6MWD after participating in pulmonary rehabilitation,
but the recipients were able to maintain pre transplant 6MWD. Li
et al. results revealed the greater the final 6MWD prior to
transplant was associated with a shorter hospital length of stay.

Li, Mathur, Chowdury,
Helen, and Singer

Effects of pulmonary
rehabilitation in
bronchiectasis: A
retrospective study

evaluate the impact of
pulmonary
rehabilitation on the
severity of ILD

Ong, Lee, Hill, Holland &
Denehy

A pilot study of pulmonary
rehabilitation and chest
physiotherapy versus chest
physiotherapy alone
in bronchiectasis

Mandal et al.

The aim of our study
was to assess the
efficacy of pulmonary
rehabilitation in
addition to regular
chest physiotherapy in
non cystic
fibrosis bronchiectasis.

Implications for practice, research,
theory

The effects of pulmonary rehabilitation were able to be
maintained for 12 months post pulmonary rehabilitation. The
results of this study also provide support that individuals with
bronchiectasis do not have a significantly different response to
pulmonary rehabilitation than recipients with COPD, which is
useful information for physicians who have concerns of referring
recipients with bronchiectasis for pulmonary rehabilitation

a pilot comparison study in bronchiectasis recipients who
received chest physiotherapy versus bronchiectasis recipients
who received chest physiotherapy (CP) and pulmonary
rehabilitation found adding pulmonary rehabilitation to CP led to
significant improvements in exercise capacity compared to
recipients who received CP alone
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The improvements in exercise capacity
was maintained for 12 weeks after the
intervention ended

6-minute Walk Distance (6MWD) as Determinant of Survival in Transplant Candidates
Exercise testing has become a convenient method of evaluating respiratory function; the
six-minute walk distance is one way to measure this. The six-minute walk has proven to be
reproducible and is tolerated by recipients with various disease severities. The six-minute walk
test evaluates the distance a person can walk on a flat, rigid surface in six-minutes; the purpose
of the test is to determine exercise tolerance and oxygen saturation during submaximal exercise
(Morales-Blanhir, 2011).
A study population of 376 recipients with diverse native diseases listed for lung
transplantation who were prospectively followed from the time of listing onward. The results of
the study found a relationship between baseline 6MWD and patient mortality (after variable
adjustment). The results indicated that in a 28 month follow up period for every 500 foot
increments in baseline 6MWD there was greater than 50% reduction in mortality-this trend was
seen across all diseases categories and through transplantation. The researchers found that the
baseline 6MWD is predictive of survival regardless of transplant status (Martinu, 2008).
In another retrospective cohort study, 51 recipients who were diagnosed with ILD
analyzed if the 6MWD is associated with survival in recipients with ILD referred for lung
transplantation. The results of the study did show that oxygen saturation and 6MWD are
associated with the risks of death in recipients with IlD who were evaluated for lung
transplantation. Oxygen desaturation with exercise is one of the common respiratory issues of
ILD; researchers of the study found that lower oxygen saturation during exercise or recovery was
associated with an increased risk of death. To conclude the results of this study found excellent
sensitivity and specificity of oxygen saturation <95% with unloaded exercise and 6MWD <
350m for prediction of death on the list for recipients with ILD for a patient with oxygen
saturation of <95% there was a 75% chance of dying on the list (Kawut, 2005).
For lung transplant candidates the 6MWD has shown high sensitivity as a predictor of
mortality. Among recipients on the waiting list for transplantation on a 6MWD of less than 300m
was associated with much earlier mortality. The 6MWD is a useful tool that represents an
accurate and efficient method of quantifying exercise tolerance.
Kenn et al. (2014) conducted a retrospective clinical pre-analysis and post-analysis of
lung transplant candidates in pulmonary rehab. The aim of their study was to see how effective
PR was in not only in recipients with COPD but in recipients with other lung diseases waiting for
1

transplant. The results of their study showed short-term comprehensive PR can significantly
improve exercise capacity. The data of this study showed two other positive effects of PR: 1)
candidates with greater exercise capacity prior to lung transplant showed favorable posttransplant outcomes, 2) candidates, both with COPD and restrictive lung diseases, showed an
increase in 6MWD. These two important positive effects support that PR is beneficial for
candidates pre-transplant and will results in better post-transplant outcomes for the patient.
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CHAPTER III
Methods
Introduction
The study contained several variables related to post-transplant outcomes. In order to
appropriately consider all factors believed to affect transplant recipient’s post-transplant hospital
outcomes and to determine the variables to be used in the study, we conducted through extensive
research literature and looked for variables that clearly demonstrated risk or protective properties
that could potential affect the hospital outcomes of transplant recipients. Institutional Review
Boards at Georgia State University and Emory University approved the study as exempted
research.
Study Design and Sample
The study is a non-probability sample of lung transplant recipients who underwent
surgery from February 8, 2007 to July 8, 2014. The information from the data set was obtained
from a secondary data source, the data warehouse at Emory University Transplant Center.
Subjects were recipients with diverse end-stage lung disease processes.
During this period the total number of recipients was 214; seven transplant recipients
were excluded due to death immediately after transplant while in the hospital. Thus, the sample
size for this study is 207 transplant recipients with a 5.0% margin of error and a 95% confidence
interval.
Measures
The instruments used to collect data on transplant recipients was the data warehouse at
Emory University Hospital and chart abstraction. Pre-transplant and post-transplant coordinators
and other healthcare disciplines update and enter the transplant recipient’s data in the data
warehouse during the pre and post-transplant phase of care. Chart abstraction was used to
collected limited data information on the transplant recipients’ participation in preoperative
pulmonary rehabilitation and six-minute walk distance.
Data Analysis Overview
Independent Variables
Three independent variables were tested in this study: 1) pulmonary rehabilitation, 2)
six-minute walk distance, and 3) total number of preoperative behaviors.
3

Preoperative Pulmonary Rehabilitation
Preoperative pulmonary rehabilitation was defined as a dichotomous variable:
participation and no participation. Participation in pulmonary rehabilitation was based on the
guidelines of the American Association of Cardiovascular and Pulmonary Rehabilitation
(AACVPR) [American Association of Cardiovascular…2004]. Participation in preoperative
pulmonary rehabilitation including participating in one of the three following levels of
rehabilitation:
•

Inpatient pulmonary rehabilitation must have: a) attended 3-5 preoperative pulmonary
sessions a week, b) for 30 to 90 minutes a session and c) for at least 4 weeks, and d)
within 6 months of transplant.

•

Transplant recipients who participated in home pulmonary rehabilitation must have
attended one inpatient session (which will provide home pulmonary instructions tailored
to disease severity and patient tolerance) and a) work-out 3-5 sessions a week, b) for 30
to 90 minutes, c) for at least 4 weeks, and d) within 6 months of transplant.

•

Transplant recipients with decline in pulmonary function must have participated in
preoperative pulmonary rehabilitation interval training: a) 10-30 minutes sessions with
breaks as needed, b) 5 to 7 days a week, c) for at least 4 weeks and d) within 6 months of
transplant.
Inpatient and home preoperative rehabilitation must have been performed on a stationary

bike where resistance can be changed and distance measured, treadmill or surface track. Upper
arm exercises should have been performed on an arm ergometry, with light weights or
Therabands. In order to decrease a possible bias towards the null, preoperative pulmonary
rehabilitation inclusion was not limited to recipients who completed pulmonary programs.
Recipients with any participation in pulmonary rehabilitation were considered as engaging in
preoperative pulmonary rehabilitation. Lung transplant recipients who did not engage in
preoperative pulmonary rehabilitation were the referent group.
Six-Minute Walk Distance (6MWD)
The 6MWD is an index used to determine the transplant recipient’s ability to perform
daily life activities. The 6MWD measures the distance a transplant candidate can walk within a
6-minute time limit; the distance is measured in feet (ft.) or meters (m). A study by Duke
University researchers found for every 50 meter increased in walk distance over 207 meters
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during 6MWD there was an increase in survival. There was approximately a 1.5 greater relative
risk of survival for lung transplant recipients who walked greater than 207 meters compared to
those who walked less than 207 meters (Martinu, Babyak, and Palmer, 2008). Based on the
results of the Duke University study, 6MWD was dichotomized into two categories. The first
category was transplant recipients who walked 207 meters and more in their last preoperative
6MWD. The second category were transplant recipients who walked less than 207 meters in their
last preoperative 6MWD. The referent group was lung transplant recipients who walked less than
207 meters during their last preoperative 6MWD.
Total Number of Preoperative Behaviors
The remaining variable is a created by two combined variable. Preoperative pulmonary
rehabilitation and 6MWD to create a new variable. The variable is an exploratory variable with
three categorical levels. The first level is no participation in preoperative pulmonary
rehabilitation and 6MWD less than 207 meters. The second level is participation in preoperative
pulmonary rehabilitation or 6MWD greater than or equal to 207 meters. The third level is
participation in preoperative pulmonary rehabilitation and greater than or equal to 207 meters.
Dependent Variables
Transplant recipients readmitted in the first 90 days post-transplant were defined as a
“yes”. Recipients not admitted in the first 90 days post-transplant were defined as a “no”. The
number of readmissions was dichotomized to two levels: less than two readmissions or greater
than two admissions in the first 90 days post-transplant. Dichotomization of this variable was
based on a study conducted by Vigneswaran et al. (2010). The study results showed early
admissions in the first 90 days post-transplant are an early predictor of recipient survival
following isolated lung transplantation. The results indicated the 90-day conditional survival at
one, three, and five years for those patients readmitted within 90 days were 76%, 59%, and 52%,
respectively. For patients not readmitted the values were respectively 93%, 80%, and 76%.
The variable length of stay was dichotomized as 12 days and less and greater than 12
days based on clinical knowledge as transplant practitioner and univariate statistics from the
current data. The results of PROC UNIVARIATE for the length of stay the mode was 14 days
and the 25% quantile was 12 days.
Further support for this dichotomization is based on clinical observations where the
average length of stay for transplant recipients is 7-14 days. The goal of the transplant team is to
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discharge safely and efficiently the new transplant recipients once they are stable to decrease the
risk of hospital acquired infection. Transplant recipients are typically discharged home 14 days
post-transplant. Further support for this dichotomization is based on clinical observations where
the average length of stay for transplant recipients is 7-14 days.
Other transplant recipients’ characteristics were gender (male/female), racial ethnicity
(Caucasian, African American, other), age (less than 20, 20-44, 45-54, 55 and older), and pretransplant diagnosis body mass index (underweight, normal, overweight, obese). Transplant
recipients’ clinical data were pre-transplant diagnosis (chronic obstructive pulmonary disease
[COPD]), idiopathic pulmonary fibrosis [IPF], sarcoidosis, cystic fibrosis, other end-stage lung
diseases), and lung laterality (single or double lung).
All analyses were conducted using Statistical Analysis System (SAS) 9.3 software. SAS
survey procedures were employed to account for complex study design. Descriptive statistics
was obtained, to summarize, the distribution of study variables. The chi-square (X2) statistic was
used to compare the differences in the distribution of participation of recipients who participated
in preoperative pulmonary rehabilitation within each recipient characteristic. The column percent
used in the two-way table was used to analyze the differences in within each category. For
example to analyze males who participated in preoperative pulmonary rehabilitation compared to
males who did not participate in preoperative pulmonary rehabilitation.
Logistic regression calculates the probability or success over the probability of failure,
the results of the analysis are in the form of an odd ratio. The dependent variable in the logistic
regression is usually dichotomous. The independent or predictor variables in the logistic
regression can take any form. Logistic regression makes no assumption about the distribution of
the independent variables. The independent variables do not have to be normally distributed,
linearly related or of equal variance within each group. The goal of logistic regression is to
predict the category of outcome for individual cases using the most parsimonious model
correctly.
Logistic regression was used to examine the association between dependent variables,
6MWD and preoperative pulmonary rehabilitation and independent variables. For all statistical
analyses, a level of α = 0.05 was used for significance testing.
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CHAPTER IV
Results
Sample Demographics
The final analytic data consisted of 207 lung transplant recipients, 128 recipients who
participated in preoperative pulmonary rehabilitation and 79 who did not participate in
preoperative pulmonary rehabilitation.
The recipients ranged in age from 16 to 73 years with a mean age 55.10 years
(SD=11.91) and a mean BMI of 25 (SD=4.48) for the study population. The largest transplant
recipient age group for both men and women were adults age 55 and older. As shown in Table
4.1 adults age 55 and older were more likely to participate in preoperative pulmonary
rehabilitation compared other age groups (p<0.05).
A stratified analysis of Africans Americans participation in preoperative pulmonary
rehabilitation, age, and gender was performed. African American males who were 55 years of
age and older were 1.54 more times likely not to participate in preoperative pulmonary
rehabilitation compared to African American females (p<0.05).
Cystic Fibrosis and other (BOOP, Apha-1) pre-transplant diagnosis have the highest
percent of recipients who did not participate in preoperative pulmonary rehabilitation. A
stratified analysis of preoperative pulmonary rehabilitation and gender while controlling for pretransplant diagnosis was completed. The results of the analysis revealed females diagnosed with
cystic fibrosis were 1.12 times more likely not to participate in pulmonary rehabilitation
compared to males diagnosed with cystic fibrosis. However, males with other pre-transplant
diagnoses were 1.32 times more likely not to participate in preoperative pulmonary rehabilitation
compared to females diagnosed with other pre-transplant diagnoses.
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Table 4.1 Transplant Recipients Pre-Transplant Demographics Characteristics and Clinical Data
Pre-Op Rehab
N = 128

No Pre-Op Rehab
N= 79

P-value

Gender
0.0550
56.25
69.62
Male
43.75
30.38
Female
Ethnic Race
0.1573
81.25
70.89
Caucasian
15.63
26.58
African American
3.13
2.53
Other
Age
0.0037
0
3.80
Less than 20
10.94
20.25
20-44
11.72
20.25
45-54
77.34
55.70
55-older
Pre transplant Diagnosis
0.0003
36.72
20.25
COPD
43.75
44.30
IPF
6.25
2.53
Sarcoidosis
3.91
0.00
Bronchiectasis
3.13
12.66
Cystic Fibrosis
6.25
20.25
Other
Pre-transplant BMI
0.5655
6.25
8.86
Underweight
38.28
41.77
Normal
42.19
41.77
Overweight
13.28
7.59
Obese
6MWD
0.0240
17.32
31.08
Less than 207 meters
82.68
68.92
207 meters and more
Laterality
0.6548
24.22
21.52
Single lung transplant
75.78
78.48
Bilateral lung transplant
Smoking History
0.1081
54.43
65.63
Former Smoker
45.57
34.38
Never Smoked
+ Numeric values in table are column percentages from Chi-square data analysis
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Table 4.2 Descriptive Summary Statistics for Pre-Transplant Recipients

Variables

Count

207
Age
207
Pre-transplant BMI
201
Six-minute Walk
Distance
Bivariate Logistic Regression

Mean
55.09662
25.0
271.1940

Standard
Deviation
11.9127222
4.47693294
90.14725527

Research Question 1: Do lung transplant recipients who engaged in preoperative
pulmonary rehabilitation differ on post-operative hospital readmissions compared to those who
did not engage in preoperative pulmonary rehabilitation?
H01: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have
an equal odds of being readmitted post 90 days compared to lung transplant recipients who did
not engage in preoperative pulmonary rehabilitation.
Table 4.3 shows regressions coefficients with an odds ratio and significance level at
α=0.05. The results indicates that the odds of being admitted post 90 days is greater for those
who engage in preoperative rehabilitation compared to those who did not engage in preoperative
pulmonary rehabilitation. Transplant recipients who engaged in preoperative pulmonary
rehabilitation were 1.77 times more likely to be readmitted within the first 90 days compared to
transplant recipients who did not engage in preoperative pulmonary rehabilitation. The null
hypothesis was rejected.
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Table 4.3 Summary of Logistic Regressions Analysis of the Association of the Effect of
Preoperative Pulmonary Rehabilitation on Transplant Recipients Readmissions in the First
90 Days Post-transplant
Readmission in First 90 Days Post Transplant
Estimate
Odds Ratio
P-value
-0.0253
1.00 (Referent group)

Parameter
Intercept
Did not participate in
preoperative
pulmonary
rehabilitation
1.77+
0.0497
Participated in
preoperative
pulmonary
rehabilitation
H02: Lung transplant recipients who engaged in preoperative pulmonary rehabilitation will have
an equal odds of having < 2 readmissions when compared to lung transplant recipients who did
not engage in preoperative pulmonary rehabilitation.
Estimates in Table 4.4,indicate that there is no difference in lung transplant recipients who
engaged in preoperative pulmonary rehabilitation when compared to lung transplant recipients
who did not engage in preoperative pulmonary rehabilitation in odds of having <2 admissions.
Therefore we fail to reject the null hypothesis.
Table 4.4 Summary of Logistic Regressions Analysis of the Association of the Effect of
Preoperative Pulmonary Rehabilitation on the Number of Post-transplant Readmissions
Number of Post-Transplant Readmissions
Parameter

Estimate

Intercept
Did not participate in
preoperative
pulmonary
rehabilitation
Participated in
preoperative
pulmonary
rehabilitation

1.2204

Odds Ratio

P-value

1.00 (Referent group)

0.65

10

0.1893

Research Question 2: Do lung transplant recipients who engaged in 6MWD differ on hospital
length of stay post-surgery compared to those who did not engage in a 6MWD?
H01: Lung transplant recipients who engaged in 6MWD will have an equal odds of having ≤ 12
day stay compared to lung transplant recipients who did not engage in 6MWD.
For research question two we reject the null hypothesis that transplant recipients who engaged in
6MWD of 207 meters or more do not differ from transplant recipients who walked less than 207
meters on hospital length of stay post-surgery. Transplant recipients who engaged in a 6MWD of
207 meters or more were 4.99 times more likely to be discharged from the hospital in less than
12 days post-transplant surgery compared to transplant recipients with a 6MWD of less than 207
meters.

Table 4.5 Summary of Logistic Regression Analysis of the Association of Effect of
Transplant Recipients last Pre-Transplant Six-minute Walk Distance on Length of Stay in
the Hospital after Transplant Surgery
Length of Stay in Hospital After Transplant Surgery
Estimate
Odds Ratio
Parameter
-2.6391
Intercept
1.00
Walked less than 207
(Referent group)
meters
4.99+
Walked 207 meters
and more

P-value

0.0101

+ 6 observations were
deleted due to missing values
for the response

Exploratory Research Question 3: Do lung transplant recipients who did not engage in both
preoperative pulmonary rehabilitation and SMWD differ on hospital admissions from those who
engaged in at least one or both of the preoperative behaviors?
There were three outcomes examined in this research question. The first outcome
examined transplant recipients who engaged in preoperative pulmonary rehabilitation or engaged
in a SWMD greater than or equal to 207 meters. The second outcome examined transplant
recipients who engaged in preoperative pulmonary rehabilitation and engaged in a SMWD was
greater than or equal to 207 meters. The third outcome, the referent group, examined transplant
recipients who did not engage in preoperative pulmonary rehabilitation and engaged in SMWD
less than 207 meters.
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Table 4.6, we reject the null hypothesis. Lung transplant recipients who did not engage in
both preoperative pulmonary rehabilitation and 6MWD do not differ on hospital admissions from
those who engaged in at least one or both of the preoperative behaviors.
Transplant recipients who participated in preoperative pulmonary rehabilitation or whose
6MWD was greater than or equal to 207 meters have 3.10 times of odds of being readmitted in
the first 90 days post-transplant compared to transplant recipients who did not participate in
preoperative rehabilitation and SMWD less than 207 meters.
Transplant recipients who participated in both preoperative pulmonary rehabilitation and
whose 6MWD was greater than or equal to 207 meters have 3.72 times the odds of being
readmitted in the first 90 days post-transplant compared to transplant recipients who did not
participate in preoperative rehabilitation and SMWD less than 2-7 meters.
Table 4.6 Summary of Logistic Regressions Analysis of the Association of the Effect of
Variable Total Number of Preoperative Behaviors Rehabilitation on Transplant Recipients
Readmissions in the First 90 Days Post-transplant

Parameter
Intercept
Did not participation
in preoperative
pulmonary
rehabilitation and
SWMD less than 207
meters
Participated in
preoperative
pulmonary
rehabilitation or
SMWD was greater
than or equal to 207
meters
Participated in
preoperative
pulmonary
rehabilitation and
SMWD was greater
than or equal to 207
meters

Readmission in First 90 Days Post-Transplant
Estimate
Odds Ratio
-0.6286
1.00
Referent group
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P-value

3.10

0.0159

3.72

0.0037

There is no difference in the number of post-transplant readmissions in the first 90 days
post-transplant between those who participated in preoperative pulmonary rehabilitation or
whose 6MWD was greater than or equal to 207 meters compared to those who did not participate
in pulmonary rehabilitation and whose SMWD was less than 207 meters (Table 4.7); we fail to
reject the null hypothesis.
Table 4.7 we fail to reject the null hypothesis. There is no difference in the number of
post-transplant readmissions in the first 90 days between those who participated in preoperative
pulmonary rehabilitation and whose 6MWD was greater than or equal to 207 meters compared to
those who did not participate in pulmonary rehabilitation and whose SMWD was less than 207
meters.
Table 4.7 Summary of Logistic Regressions Analysis of the Association of the Effect of
Variable Total number of preoperative behaviors on the Number of Post-transplant
Readmissions in the first 90 days
Number of Post-Transplant Readmissions in First 90 Days
Estimate
Odds Ratio
P-value
Parameter
1.5581
Intercept
1.00
Did not participation
Referent group
in preoperative
pulmonary
rehabilitation and
SWMD less than 207
meters
0.55
0.2809
Participated in
preoperative
pulmonary
rehabilitation or
SMWD was greater
than or equal to 207
meters
0.50
0.1916
Participated in
preoperative
pulmonary
rehabilitation and
SMWD was greater
than or equal to 207
meters
In Table 4.8, we fail to reject the null hypothesis; there is no difference between
recipients who participated in preoperative pulmonary rehabilitation or who 6MWD was greater
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than or equal to 207 meters compare to transplant recipients who did not participate in
preoperative pulmonary rehabilitation or complete a 6MWD.
However, transplant recipients who participated in preoperative pulmonary rehabilitation
and whose 6MWD was greater than or equal to 207 meters had 2.34 times the odd of having a
length of stay of 12 days or less after transplant surgery, so we reject the null hypothesis.

Table 4.8 Summary of Logistic Regression Analysis of the Association of the Variable Total
number of preoperative behaviors on Length of Stay in the Hospital after Transplant
Surgery
Length of Stay in the Hospital After Transplant
Odds Ratio
P-value
Parameter
1.00
Did not participation in preoperative
Referent group
pulmonary rehabilitation or complete a
6MWD
1.82
0.1202
Participated in preoperative pulmonary
rehabilitation or SMWD was greater than
or equal to 207 meters
2.34
0.0222
Participated in preoperative pulmonary
rehabilitation and SMWD was greater
than or equal to 207 meters
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Chapter V
Discussion and Conclusion

The findings of the study did and did not support the study’s original research questions and
hypotheses.
The first research question related to the association between participation in preoperative
pulmonary rehabilitation and readmissions in the first 90 days post-transplant yield unusual
findings. The results of regressions analysis showed a significant association between recipients’
who participated in preoperative pulmonary rehabilitation and readmission in the first 90 days
post-transplant.
The second research question’s focus was on the association between preoperative
pulmonary rehabilitation and number of hospital admissions in the first 90 days post-transplant.
As with the results showed recipients who participated in preoperative pulmonary rehabilitation
were more likely to have more than two hospital readmissions compared to those who did not
participate in preoperative pulmonary rehabilitation. The results of this association were not
statistically significant.
The next research question focused on recipients 6MWD and length of stay in the
hospital. The results show an association between recipients’ who participate in preoperative
pulmonary rehabilitation or whose 6MWD was greater than or equal to 207 meters and recipients
who participated in pulmonary rehabilitation and whose 6MWD was greater than 207 meters
found that there was an association of readmission in the first 90 days post-transplant.
The number of preoperative behaviors research questions results was a summary of all
previous behaviors tested in other research questions. The results of this research question
yielded unexpected results. Recipients who participated in preoperative pulmonary rehabilitation
and/or had a 6MWD greater than or equal to 207 meters were more likely to be admitted in the
first 90 days post-transplant.
Preoperative pulmonary rehabilitation is believed to be beneficial or have an almost
“protective” effect post-transplant. Conversely, the results showed transplant recipients who
participated in pulmonary rehabilitation and/or had a 6MWD greater than or equal to 207 meters
were readmitted in the first 90 days. We assessed the other baseline covariates for potential
answers to why this association may have occurred, but further analysis of the covariates did not
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present additional findings. We do, however, have a theory and plausible explanation for the
observed observations.
Based on standard clinical practice and observations at Emory University, plausible
explanations for these findings are as follows. It is possible that transplant recipients who remain
actively engaged while waitlisted tend to be more proactive in their post-transplant care.
Observations of these patients indicate that they are more likely to contact the transplant team
when they have a medical concern or issue. Since the greatest risk of mortality for transplant
recipients is the first year post-transplant, the Emory transplant team is aggressive in ensuring
recipients are healthy and very cautious when recipients show signs of illness. When the
proactive transplant recipient who is less than 90 days post-transplant calls with a medical
illness, the transplant teams will more than likely admit the transplant recipient. These
explanations are based upon experiences of the researchers and therefore to substantiate and test
this theory. A study is needed with larger sample size to understand the results better.
There was an association between a recipient’s 6MWD (greater than or equal to 207
meters) and length of stay of 12 days or less. The results of logistic regression analysis among
recipients’ who participate in preoperative pulmonary rehabilitation or whose 6MWD greater
than or equal to 207 meters and recipients who participated in pulmonary rehabilitation and
whose 6MWD was greater than 207 meters found that there was an association of readmission in
the first 90 days post-transplant. Participation in preoperative pulmonary rehabilitation and
6MWD of greater than or equal to 207 meters was associated with a length of stay of 12 days or
less in the hospital after transplant surgery. This finding supports the data of previous research
studies of the importance of pulmonary rehabilitation of increasing 6MWD. This finding also
illustrates the importance of both participation in preoperative pulmonary rehabilitation and
6MWD on transplant recipients outcomes.
Some results in the present study were not statistically significance, however may have
practical significance on recipient outcomes. Recipients who participated in preoperative
pulmonary rehabilitation or whose 6MWD was greater than or equal to 207 meters were 1.82
times more likely to be discharged in 12 days or less than those who did not participate in
preoperative pulmonary rehabilitation or complete a 6MWD. Though this finding was not
statistically significant, it is possible that is still has relevance, and further test with larger sample
size is needed.
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The outcomes were assessed for potential confounding. There was an association
between age and length of stay after transplant. When logistic regression was used to adjust for
confounding, the odds ratio increased from 4.99 to 5.10, and the p-value changed from 0.0101 to
0.0093.Since the adjusted odds ratio differed from the crudes odd ratio by less than 10%, there
was no confounding by the covariate age. No further confounding was found between outcomes
and other covariates.
There are a very limited number of studies to which the findings in this study could be
compared. Research studies on the outcomes of preoperative pulmonary rehabilitation are
focused on the physiological outcomes mainly in non-transplant recipients. Rochester (2008)
physiological benefits of preoperative rehabilitation in the post-transplant phase. Rochester states
preoperative pulmonary rehabilitation will reduce minute ventilation at comparable workloads,
restore normal or near-normal lung function and gas exchange and elimination of substantial
ventilatory limitation to exercise. Improvement in these respiratory physiological functions may
enable the lung transplant recipient to exercise at higher intensities and achieve greater gains in
aerobic and exercise fitness. Rochester also states it is not known whether preoperative
pulmonary rehabilitation increases survival to surgery, increases a recipients’ tolerance of
surgery, reduces post-surgical complications or improves post-surgical outcomes.
Six-minute walk distance (6MWD) research studies aims are to assess the benefits of
interventions on the increase or decrease in 6MWD. Other studies on 6MWD focus on 6MWD
predicting survival or indicating transplant candidates prognosis. Martinu et al. conducted an
extensive large prospective two-center study. The cohort for the study was patients listed for
lung transplantation. The researchers used Cox proportional hazard model to determine the
importance of 6MWD in predicting the candidates’ survival. The results of the study revealed a
50% decrease in mortality for every 500 feet (152.4m) increase in 6MWD.

Strengths
The strengths of the study are the finding of the importance of 6MWD of the hospital
outcomes. The finding supports the importance of recipients participation in preoperative
pulmonary rehabilitation to achieve better postsurgical outcomes.

Limitations
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The lack of associations in the number of readmissions may have been due to smaller
sample size and insufficient power in the study design to detect differences at the p<.05 level. .
The total sample size was only 207 transplant recipients. The male Caucasian population was the
largest population in the study compared to females and other ethnic races.
The referent group used in the study was not a true control group. In healthcare, it is unethical to
withhold a treatment that may be beneficial for a patient, so the referent group used was
transplant recipients who decided not to participate in preoperative pulmonary rehabilitation. The
data collected on transplant recipients’ participation in preoperative pulmonary rehabilitation was
obtained by chart abstraction. The transplant recipients’ participation in preoperative
rehabilitation was verified by only one person. In order to decrease potential misclassification,
the recipients’ participation in pre-operative rehabilitation should be verified by someone else.
Six values for recipients 6MWD were missing. The values were unable to be located during chart
abstraction. The six missing values did not affect the normality of 6MWD variable. When
assessed for skewness, 6MWD was normal (not skewed to the left or the right).

Future Study
Studies are needed that explain the benefits of preoperative pulmonary rehabilitation on
post-transplant outcomes. Previous research studies regarding preoperative pulmonary
rehabilitation primarily focused on the psychological benefits of preoperative pulmonary
rehabilitation. Research needs to be done to show the effects of pre-operative pulmonary
rehabilitation on decreasing surgical complications, surgical outcomes, and hospital outcomes
(i.e. time on the mechanical ventilator and number of admissions). This study could be used as a
baseline for future studies. The next study to assess the benefits of preoperative pulmonary
rehabilitation on post-transplant outcomes would ideally be a prospective study design. A
prospective cohort study with a larger sample size that would occur in transplant center where
preoperative pulmonary rehabilitation was still optional. The researchers would follow the
transplant recipients from the time they are listed for lung transplant until they are one year posttransplant. The researchers would compare the hospital outcomes investigated in this study at
three months, six months, nine months, and one year post-transplant. A study structured with
four follow up periods would provide the transplant research community with data on the
18

importance of preoperative pulmonary rehabilitation on hospital outcomes during the first year
post-transplant when the chance of survival is low.

Conclusion
In the first year post-transplant 78% of the patients survive. There are general risk for any
major surgery including lung transplant. There are increased risk of pulmonary postoperative
complications for the following risk factors: upper abdominal and thoracic surgery, surgery
greater than 3 hours, underlying chronic pulmonary disease, and history of smoking, age greater
than 60, obesity, and poor exercise tolerance. Transplant candidates recipients have at least 5 to 7
of the risk factors listed which puts them at a high risk for pulmonary postoperative
complications. Based on this list of risk factors it is vital transplant recipients have an
understanding of the importance perioperative pulmonary rehabilitation plays in their posttransplant hospital outcomes.
The present analysis examined the relationship between preoperative rehabilitation,
6MWD and hospital outcomes among transplant recipients. The association between 6MWD and
length of stay has beneficial outcomes for the recipient and healthcare. Recipients with a 6MWD
greater than or equal to 207 meters and who participated in preoperative pulmonary
rehabilitation had a decreased length of stay in the hospital. The average cost per day for an
inpatient stay in the state of Georgia averages $1605 per a day. The average length of stay for
transplant recipients averages 7 to 14 days after transplant. A transplant recipient who
participated in pre-operative pulmonary rehabilitation and whose 6MWD was greater than or
equal to 207 meters length of stay was less than or equal to 12 days. This averages about $3210
less in hospital costs. This study supports previous literature on the importance of pulmonary
rehabilitation, but also suggests the relationship between pulmonary rehabilitation and
readmissions is complex.
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